Diligent Pharma Releases 63 Vendor Questionnaire Templates to Standardize Qualification

Princeton, NJ — May 21, 2026 — Diligent Pharma, a Quality and Compliance company specializing in Vendor qualification and management for clinical trials, today announced the release of 63 vendor qualification questionnaire templates mapped to current regulations. Now available through the Diligent360 and DiligentRespond platforms and spanning 59 clinical trial service categories, the templates are designed to address two persistent challenges facing the industry: the growing compliance burden on Sponsors evaluating and selecting new Vendors, and the repetitive questionnaire and audit workload carried by Vendors working across multiple Sponsor programs. 

Under ICH E6(R3), Sponsors bear responsibility for demonstrating a risk-based approach to Vendor selection: evaluating capabilities and systems, assessing risk, and maintaining a documented record substantiating their decisions for every third-party service provider engaged in a clinical trial program. As regulatory expectations continue to evolve, ensuring that qualification questionnaires remain comprehensive and aligned with current standards represents an ongoing compliance obligation for Sponsor organizations. 

At the same time, Vendors working across multiple clinical programs routinely complete overlapping questionnaires from different Sponsors, answering similar questions in different formats, with no standardized approach. The result is duplicated effort, slower qualification timelines, and administrative overhead that delays trial startup on both sides. 

“Vendor qualification has long been one of the most time-consuming and inconsistently executed parts of trial startup. These templates give Sponsors confidence that they are asking the right questions of potential trial partners, and give Vendors a way to engage more efficiently with every new prospect.” – Peter Haessig, Head of Client Partnerships at Diligent Pharma 

WHAT THIS MEANS FOR SPONSORS 

The 63 questionnaire templates were built to address this dysfunction. For Sponsors, the impact is measurable. 

Qualifying a single Vendor can take three to five months or more. For Sponsors working with Diligent, that same process can be completed in just days. On average, Sponsors see a 78% reduction in qualification timelines and 60% cost savings, driven by a standardized and centralized process for collecting Vendor qualification information.  

For Sponsors, access to the templates means greater confidence in the completeness and quality of Vendor selection data, and a more defensible record of Vendor decisions. 

The templates can be customized to reflect a Sponsor's specific protocol requirements, allowing additional questions to be added where a particular program demands greater depth of information. 

WHAT THIS MEANS FOR VENDORS 

For Vendors, the standardized questionnaire templates significantly reduce the burden of responding to compliance requests across multiple Sponsor programs. Using DiligentRespond, Vendors complete their questionnaire responses once and reuse those answers to populate future requests from other Sponsors, eliminating the need to re-enter the same information for each new engagement. The result is faster response times, fewer administrative demands on Vendor teams, and a more efficient path to doing business with new Sponsors. 

ABOUT THE TEMPLATES 

The 63 questionnaire templates were developed by Diligent's team of subject matter experts, built on years of experience conducting Vendor qualification assessments and working with clinical trial Sponsors and Vendors across a wide range of therapeutic areas and program types. The templates are validated against current regulatory expectations and organized across seven service category groups: 

• CRO 

• Investigational Product 

• Labs 

• Regulatory Affairs 

• Safety 

• Site-Patient 

• Technology 

AVAILABILITY 

The 63 vendor qualification questionnaire templates are available now through Diligent360, Diligent Pharma's platform for centralized Vendor qualification and management. Pharmaceutical and biotech Sponsors can access the templates immediately through the platform. Organizations interested in learning more about Diligent Pharma's approach to Vendor qualification can visit diligentpharma.com or contact Diligent Pharma's Client Partnerships team to schedule a demonstration. 

About Diligent Pharma 

Diligent Pharma is a Quality and Compliance company specializing in Vendor qualification and management for clinical trials. Headquartered in Princeton, New Jersey, Diligent Pharma connects pharmaceutical and biotech Sponsors to a global network of qualified clinical trial service providers through its Diligent360 platform. The company combines deep regulatory expertise with advanced technology solutions to transform the Vendor qualification process, enabling Sponsors to launch trials faster while maintaining the highest standards of compliance and quality. 

Sponsors can access the Diligent360 platform to discover pre-qualified service providers, access existing qualification reports, and make confident, risk-informed Vendor decisions that accelerate trial startups while reducing qualification costs. Clinical trial service providers can join Diligent's qualified Vendor network to gain visibility to Sponsors worldwide, manage questionnaire responses efficiently through DiligentRespond, and undergo a single rigorous qualification assessment rather than hosting redundant, individual Sponsor audits. With an unwavering dedication to helping life-saving treatments reach patients faster, Diligent Pharma is transforming Vendor management across the clinical trial industry.